| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) |
Enrollment closed, study ongoing |
| 2026-08-14 | NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) |
date change Primary completion pushed: 2026-06 -> 2027-06 |
| 2026-08-14 | NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) |
date change Completion pushed: 2026-06 -> 2027-06 |
| 2026-08-12 | NCT07100730 Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of… |
Trial sites expanded: 4 -> 9 locations |
| 2026-08-02 | NCT05847348 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients |
overall status: Recruiting → Unknown |
| 2026-07-24 | NCT07052214 PSMA PET Combined With MRI for the Detection of PCa |
Enrollment increased: 204 -> 338 participants |
| 2026-07-24 | NCT07052214 PSMA PET Combined With MRI for the Detection of PCa |
Trial sites expanded: 1 -> 18 locations |
| 2026-07-24 | NCT07052214 PSMA PET Combined With MRI for the Detection of PCa |
date change Primary completion pushed: 2026-06 -> 2027-01 |
| 2026-07-24 | NCT07052214 PSMA PET Combined With MRI for the Detection of PCa |
date change Completion pushed: 2026-11 -> 2027-04 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06750419 | 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT07197580 | Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or… | ccRCC | Recruiting |
| NCT06520345 | The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT07052214 | PSMA PET Combined With MRI for the Detection of PCa | PCA | Recruiting |
| NCT07100730 | Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of… | Neoplastic Disease | Recruiting |
| Phase 1 | |||
| NCT05868174 | Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX… | Solid Tumor, Adult | Recruiting |
| NCT07197645 | Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain | Bone Pain | Recruiting |
| NCT05450744 | 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) | Neoplastic Disease | Active, Not Recruiting |